107 related articles for article (PubMed ID: 25555733)
21. Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP).
Griffin RJ; Srinivasan S; Bowman K; Calvert AH; Curtin NJ; Newell DR; Pemberton LC; Golding BT
J Med Chem; 1998 Dec; 41(26):5247-56. PubMed ID: 9857092
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors.
Gangloff AR; Brown J; de Jong R; Dougan DR; Grimshaw CE; Hixon M; Jennings A; Kamran R; Kiryanov A; O'Connell S; Taylor E; Vu P
Bioorg Med Chem Lett; 2013 Aug; 23(16):4501-5. PubMed ID: 23850199
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
Wells GJ; Bihovsky R; Hudkins RL; Ator MA; Husten J
Bioorg Med Chem Lett; 2006 Mar; 16(5):1151-5. PubMed ID: 16359865
[TBL] [Abstract][Full Text] [Related]
24. Potent beta-cell protection in vitro by an isoquinolinone-derived PARP inhibitor.
Burkart V; Blaeser K; Kolb H
Horm Metab Res; 1999 Dec; 31(12):641-4. PubMed ID: 10668915
[TBL] [Abstract][Full Text] [Related]
25. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
[TBL] [Abstract][Full Text] [Related]
26. Docosahexaenoic acid and tetracyclines as promising neuroprotective compounds with poly(ADP-ribose) polymerase inhibitory activities for oxidative/genotoxic stress treatment.
Cieslik M; Pyszko J; Strosznajder JB
Neurochem Int; 2013 Apr; 62(5):626-36. PubMed ID: 23439385
[TBL] [Abstract][Full Text] [Related]
27. Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture.
Sakaue M; Mori N; Okazaki M; Ishii M; Inagaki Y; Iino Y; Miyahara K; Yamamoto M; Kumagai T; Hara S; Yamamoto M; Arishima K
J Neurosci Res; 2008 Nov; 86(15):3427-34. PubMed ID: 18627028
[TBL] [Abstract][Full Text] [Related]
28. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
Putt KS; Hergenrother PJ
Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of novel imidazo[4,5-c]pyridinecarboxamide derivatives as PARP-1 inhibitors.
Zhu Q; Wang X; Chu Z; He G; Dong G; Xu Y
Bioorg Med Chem Lett; 2013 Apr; 23(7):1993-6. PubMed ID: 23481647
[TBL] [Abstract][Full Text] [Related]
30. A scintillation proximity assay for poly(ADP-ribose) polymerase.
Cheung A; Zhang J
Anal Biochem; 2000 Jun; 282(1):24-8. PubMed ID: 10860495
[TBL] [Abstract][Full Text] [Related]
31. Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold.
Giannini G; Battistuzzi G; Vesci L; Milazzo FM; De Paolis F; Barbarino M; Guglielmi MB; Carollo V; Gallo G; Artali R; Dallavalle S
Bioorg Med Chem Lett; 2014 Jan; 24(2):462-6. PubMed ID: 24388690
[TBL] [Abstract][Full Text] [Related]
32. In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells.
Le TV; Suh JH; Kim N; Park HJ
Bioorg Med Chem Lett; 2013 May; 23(9):2642-6. PubMed ID: 23522835
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of tricyclic derivatives containing a non-aromatic amide as inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
Park CH; Chun K; Joe BY; Park JS; Kim YC; Choi JS; Ryu DK; Koh SH; Cho GW; Kim SH; Kim MH
Bioorg Med Chem Lett; 2010 Apr; 20(7):2250-3. PubMed ID: 20189385
[TBL] [Abstract][Full Text] [Related]
35. Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress.
Thorslund T; von Kobbe C; Harrigan JA; Indig FE; Christiansen M; Stevnsner T; Bohr VA
Mol Cell Biol; 2005 Sep; 25(17):7625-36. PubMed ID: 16107709
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of poly(adenosine diphosphate-ribose) polymerase using quinazolinone nucleus.
Hemalatha K; Madhumitha G
Appl Microbiol Biotechnol; 2016 Sep; 100(18):7799-814. PubMed ID: 27470142
[TBL] [Abstract][Full Text] [Related]
37. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite.
Radovits T; Zotkina J; Lin LN; Bömicke T; Arif R; Gerö D; Horváth EM; Karck M; Szabó C; Szabó G
Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528
[TBL] [Abstract][Full Text] [Related]
38. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of some novel quinazolin-4(3H)-one hybrid molecules as potent urease inhibitors.
Menteşe E; Akyüz G; Yılmaz F; Baltaş N; Emirik M
Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800182. PubMed ID: 30375666
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of phenolic hydrazide hydrazones as potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors.
Islam R; Koizumi F; Kodera Y; Inoue K; Okawara T; Masutani M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3802-6. PubMed ID: 25042255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
